- SPANNR
- Posts
- Issue #49
Issue #49
Issue #49
May 4, 2023 | Issue #49
Good afternoon. Welcome back to another issue of Spannr.In this week's newsletter:š„ Strategic assets for longevity companiesš£ Longevity wants YOUšø This week in fundingš Good reads from around the web
Decoding the Role of Advisory Boards in Longevity Biotech
Why do longevity biotech startups showcase a public board of advisors,
while tech startups often shy away from it?
Itās a question five longevity thought-leaders asked themselves recently while discussing the formation, purpose, and advantages of
Scientific Advisory Boards (SABs)
within the context of longevity biotech startups.
In our
, Andy D. Lee, Anahit Campbell, Alexey Strygin, David Stanete, and Christin Glorioso, provide founders with the insights necessary to decide whether assembling an SAB is right for them, or why they might want to consider advising startups themselves.
Introducing the Spannr Jobs Board and Recruitment Service
On any given week, the Spannr team engages with dozens of individuals in the longevity industry, from scientists, students, and professors to entrepreneurs, biohackers, and investors.
In these discussions, we often focus on the future and the immense potential that longevity biotech possesses.
However, as pioneers on the brink of groundbreaking technology, we must also acknowledge the challenges the industry faces.
The three limitations we most often hear come up in these conversations are:
Political action
Capital
Talent
While we donāt have much sway over politicians, beyond working with organizations such as
, we believe we have made a positive impact on the capital front by bringing dollars and awareness to the industry through our
,
, and
.
But, regardless of increased attention and funding, there's still a
people
problem. We simply need more brains focused on the future of healthcare.
Thatās why, Spannr is proud to announce the launch of our
and recruitment team.
Starting today, job seekers in the longevity field can browse through
hundreds of listings on our site
.
If you're a company seeking exceptional candidates, you can now promote your job openings through Spannr as well.
And for an even more hands-on approach, we've assembled a fantastic team of recruiters to help fill positions.
š
To check out the jobs board, simply click here
. And please reach out if you have any feedback!
Swiss-based longevity startup, Biolytica, announced this week that it has successfully secured funding totaling CHF 5.25 million ($5.8 million) from the Maximon Longevity Co-Investment Fund to build out an AI-driven longevity platform
Ossium Health was awarded $3.46 million in funding from the California Institute of Regenerative Medicine (CIRM) to advance the development of OSSM-007 for the treatment of Steroid-Refractory Acute Graft versus Host Disease (GVHD)
Venture Capital firm, LongeVC, this week invested in Melio, a health technology startup that aims to improve patient outcomes & quality of life with a rapid blood testing platform
The Secrets of Aging Are Hidden in Your Ovaries (Wired)
Mount Sinai Launches Institute for Regenerative Medicine (GEN)
New Alzheimerās drug slows cognitive decline by 35%, trial results show (The Guardian)
Inside the Secretive Life-Extension Clinic (Wired)
UT creates device that reads minds, turns thoughts into text (UT News)
Immune system profiles of extremely long-lived people (NIA)
Can a Kidney Transplant Drug Keep You From Aging? (WSJ)
Scientists Dramatically Extend Cell Lifespan in Anti-Aging Breakthrough (Vice)
Performance:
Latest Price: $107.417d-Return: 8.60%Market Cap: $11.00b
ABOUT SPANNR
We are dedicated to helping people understand the biggest business and health story of all time: the unprecedented transformation of society that will result from extending human healthspan and lifespan.
If you have any questions about Spannr or want to get to know us better,
ā we'd love to hear from you. We appreciate your interest in what we are creating.